StocksI › ITCI

Intra-Cellular Therapies, Inc. (ITCI) — Earnings Call X-Ray

Our AI read all 32 of ITCI's earnings calls (2016–2024) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.

Latest Call Grade
🔒
Q3 2024 · sign up to see
Previous Call Grade
C+
Q2 2024
Expected Move
🔒
next 45 days · members
Calls Analyzed
32
2016–2024
Avg Candor
6/9
evasion 3.7/9
Guidance RaisedPromotional ToneSkeptic ReassuredCritic AmmunitionFounder-LedVolume Step-UpEarly Product, Fast GrowthDemand Accelerating

Call-by-call analysis

🔒 Q3 2024 earnings call 2024-10-30 NEWEST

Guidance: ■■■■■Demand: ■■■■■■ Margins: ■■■■Backlog: ■■■■ ■ analysts, ■■ questionsexpected move ±■■%
Candor /9
Specificity /9
Evasion /9
Stress /9

Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.

🔒 The Q3 2024 call grade is ready
The full 37-point AI read of ITCI's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock

C+ Q2 2024 earnings call 2024-08-07 move ±9.1%

Management raised guidance against accelerating demand. The delivery was rich in specifics, promotional in tone.

Guidance: raisedDemand: acceleratingPricing: stableHeadcount: growing 14 analysts · 20 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up ahead
Candor 6/9
Specificity 7/9
Evasion 4/9
Confidence 8/9
Uncertainty 3/9
Promotion 7/9
Stress 2/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

C+ Q1 2024 earnings call 2024-05-07 move ±18.5%

Management held guidance steady against accelerating demand. The delivery was rich in specifics, promotional in tone.

Guidance: maintainedDemand: acceleratingPricing: stableHeadcount: growing 16 analysts · 23 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up ahead
Candor 6/9
Specificity 7/9
Evasion 3/9
Confidence 8/9
Uncertainty 4/9
Promotion 7/9
Stress 2/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

B Q4 2023 earnings call 2024-02-22 move ±10.1%

Management raised guidance against accelerating demand and contracting margins. The delivery was rich in specifics, promotional in tone.

Guidance: raisedDemand: acceleratingMargins: contractingPricing: under pressureHeadcount: growing 13 analysts · 19 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Early product, fast growth⚑ Reads rehearsed
Candor 6/9
Specificity 7/9
Evasion 3/9
Confidence 8/9
Uncertainty 4/9
Promotion 7/9
Stress 2/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

A Q3 2023 earnings call 2023-11-02 move ±13.3%

Management raised guidance against accelerating demand. The delivery was unusually candid, rich in specifics.

Guidance: raisedDemand: acceleratingMargins: stablePricing: stableHeadcount: growing 12 analysts · 18 questions
✓ Clean call✓ Skeptic reassured⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up ahead
Candor 7/9
Specificity 8/9
Evasion 3/9
Confidence 8/9
Uncertainty 3/9
Promotion 6/9
Stress 2/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
NO Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

B Q2 2023 earnings call 2023-08-03 move ±7.3%

Management raised guidance against accelerating demand. The delivery was rich in specifics.

Guidance: raisedDemand: acceleratingPricing: stableHeadcount: growing 12 analysts · 16 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubts✓ Early product, fast growth
Candor 6/9
Specificity 7/9
Evasion 3/9
Confidence 8/9
Uncertainty 3/9
Promotion 6/9
Stress 2/9
Complexity 6/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

C Q1 2023 earnings call 2023-05-04 move ±9.4%

Management held guidance steady against accelerating demand. The delivery was rich in specifics.

Guidance: maintainedDemand: acceleratingPricing: stableHeadcount: growing 13 analysts · 14 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubts✓ Early product, fast growth
Candor 6/9
Specificity 7/9
Evasion 4/9
Confidence 8/9
Uncertainty 3/9
Promotion 6/9
Stress 2/9
Complexity 4/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

B Q4 2022 earnings call 2023-03-01 move ±13.2%

Management raised guidance against accelerating demand. The delivery was rich in specifics.

Guidance: raisedDemand: acceleratingPricing: under pressureHeadcount: growing 12 analysts · 14 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubts✓ Early product, fast growth
Candor 6/9
Specificity 7/9
Evasion 3/9
Confidence 8/9
Uncertainty 3/9
Promotion 6/9
Stress 2/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

Earlier calls

CallDateGradeGuidanceDemandMarginsCandorEvasion
Q3 2022 2022-11-03 C noneacceleratingstable 6/9 4/9
Q2 2022 2022-08-09 D maintainedacceleratingcontracting 6/9 5/9
Q1 2022 2022-05-10 B+ maintainedacceleratingcontracting 7/9 2/9
Q4 2021 2022-03-01 C noneacceleratingcontracting 6/9 4/9
Q3 2021 2021-11-09 B noneacceleratingunclear 6/9 4/9
Q2 2021 2021-08-09 C maintainedacceleratingcontracting 6/9 3/9
Q1 2021 2021-05-10 C+ maintainedacceleratingcontracting 6/9 3/9
Q4 2020 2021-02-25 C maintainedacceleratingcontracting 6/9 4/9
Q3 2020 2020-11-09 D noneacceleratingunclear 6/9 5/9
Q2 2020 2020-08-10 C+ noneacceleratingunclear 6/9 2/9
Q1 2020 2020-05-10 F maintainedunclearcontracting 5/9 4/9
Q4 2019 2020-03-02 C noneunclearcontracting 6/9 4/9
Q3 2019 2019-11-05 D noneunclearcontracting 6/9 5/9
Q1 2019 2019-05-08 D noneunclearunclear 6/9 5/9
Q4 2018 2019-02-27 D noneunclearcontracting 5/9 4/9
Q3 2018 2018-11-07 C maintainedunclearcontracting 6/9 3/9
Q2 2018 2018-08-04 D noneunclearcontracting 5/9 4/9
Q4 2017 2018-03-01 D noneunclearcontracting 6/9 5/9
Q3 2017 2017-11-08 B noneunclearunclear 6/9 3/9
Q4 2016 2017-03-01 F noneunclearunclear 5/9 6/9
Q3 2016 2016-11-09 F maintainedunclearunclear 6/9 4/9
Q2 2016 2016-08-04 D noneunclearcontracting 5/9 5/9
Q1 2016 2016-05-01 B+ maintainedunclearunclear 7/9 2/9
Q4 2015 2016-02-25 B maintainedunclearcontracting 6/9 3/9

Research question bank — earlier calls

During our 1,600-question research program, batches of experimental hypotheses were tested directly against some of ITCI's earlier calls. The YES answers — the rare hits — are shown; click any question to see every company that matched it. Full list: the question bank.

D Q4 2017 earnings call 2018-03-01

331 more research questions answered NO

D Q2 2016 earnings call 2016-08-04

1 more research questions answered NO

How to read this page

The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.

Companies with similar call quality

AA · Alcoa CorporationAAALF · Aareal Bank AGAABKF · Aareal Bank AGAAGIY · AIA Group LimitedAAL · American Airlines Group AAPL · Apple Inc.

ITCB   All “I” companies    ITCL

Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.